help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, X.-M.
Right arrow Articles by Lightman, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X.-M.
Right arrow Articles by Lightman, S. L.
Endocrinology Vol. 138, No. 10 4351-4357
Copyright © 1997 by The Endocrine Society


ARTICLES

Emergence of an Isolated Arginine Vasopressin (AVP) Response to Stress after Repeated Restraint: A Study of Both AVP and Corticotropin-Releasing Hormone Messenger Ribonucleic Acid (RNA) and Heteronuclear RNA1

Xin-Ming Ma2, Andrew Levy and Stafford L. Lightman

Dorothy Crowfoot Hodgkin Laboratories, Department of Medicine, University of Bristol, Bristol BS2 8HW, United Kingdom

Address all correspondence and requests for reprints to: Stafford Lightman, Ph.D., Dorothy Crowfoot Hodgkin Laboratories, Department of Medicine, University of Bristol, Marlborough Street, Bristol BS2 8HW, United Kingdom. E-mail: Stafford.Lightman{at}bristol.ac.uk


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The hypothalamic-pituitary-adrenal axis adapts to periods of chronic or repeated stress. We have now investigated whether there is any differential effect of repeated immobilization stress on CRH and arginine vasopressin (AVP) gene transcription in the hypothalamic paraventricular nucleus (PVN), using probes for both intronic and exonic sequences of the AVP and CRH genes. Daily restraint for 13 days had no significant affect on basal corticosterone level, CRH heteronuclear RNA (hnRNA), CRH messenger RNA (mRNA), AVP hnRNA, or AVP mRNA. After the final episode of acute restraint, on day 14, there was a rapid increase in plasma corticosterone and AVP hnRNA level in the parvocellular subdivision of the PVN, a slower increase in AVP mRNA level in the parvocellular subdivision of the PVN, but no significant change in either CRH hnRNA or CRH mRNA in the PVN. The increase in AVP hnRNA and mRNA was specific to the parvocellular PVN, because there was no change in either transcript in the magnocellular cells of this nucleus. This isolated response is in marked contrast to naive rats, which show a predominant CRH hnRNA and mRNA response, and infers that part of the adaptation to repeated stress results from a down-regulation of CRH gene responsiveness with maintenance or even a compensatory increase in the AVP gene response.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ALTHOUGH both CRH and arginine vasopressin (AVP) from the parvocellular cells of the paraventricular nucleus (PVN) are known to stimulate ACTH secretion (1, 2), CRH is accepted to be the most important factor in mediating the stress response (3, 4, 5). AVP is colocalized in up to 50% of CRH-positive neurons in the PVN under normal resting conditions (6, 7) and acts both as a weak ACTH secretagogue on its own, and synergistically with CRH (8, 9, 10, 11, 12). It has been repeatedly demonstrated that acute stress results in increased levels of CRH messenger RNA (mRNA) in the PVN (13, 14, 15, 16, 17, 18, 19, 20). Changes of AVP mRNA in the parvocellular subdivision of the PVN, in response to acute stress, are less marked but nonetheless do occur (13, 21, 22, 23). However, the response of CRH mRNA to repeated and chronic stresses is much more complex. Depending on the stimulus used, CRH mRNA in the PVN may increase (19, 24, 25, 26, 27, 28, 29), decrease (30), or remain unchanged (14). Adaptation of the CRH mRNA response rapidly appears after repeated restraint stress (14), as does desensitization of the pituitary ACTH response (31, 32). On the other hand, repeated stress is associated with a sensitization of corticotropes to AVP (33), and there is evidence for a role of AVP in sustaining hypothalamic-pituitary-adrenal (HPA) responsiveness in the rat (9). Furthermore, there is now evidence that AVP has a specific role in repeated and chronic stress paradigms (30, 34, 35).

Recent studies have demonstrated that CRH heteronuclear RNA (hnRNA) and AVP hnRNA levels in the PVN increase rapidly in response to acute stress (23, 36, 37, 38). Because of the very short half-life of hnRNA, these changes reflect gene transcription much better than the more stable mRNA. We have recently published a detailed time course of the CRH and AVP hnRNA and mRNA responses to acute restraint stress (20) and have now gone on to detail how this response changes in animals previously exposed to 13 days of daily restraint.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Adult male Wistar rats, weighing 225–250 g, were divided into nine groups (n = 6 or 7). One control group of animals was simply handled daily and killed on the morning of day 14. One group was restrained daily for 90 min for 13 days and killed without further restraint on day 14. The other 7 groups were restrained daily for 13 days and on day 14 all had a final episode of restraint. Four groups were removed after 15, 30, 60, and 90 min of restraint and were killed immediately. The final three groups were returned to their home cages after 90 min restraint and killed at 2, 3, and 4 h after the start of restraint (equivalent to 1/2, 1 1/2, and 2 1/2 h after the return to their home cages).

Animals were killed by decapitation. Trunk blood was collected into heparinized tubes and the brains removed and frozen on dry ice. Then 12-µm sections were cut through the medial parvocellular division of the PVN and thaw mounted on twice-gelatin-coated slides and stored at -80 C. Before hybridization, sections were air dried at room temperature and fixed with 4% formaldehyde for 5 min at room temperature, washed 3 times with PBS, and then incubated in 0.25% acetic anhydride in 0.1 M triethanolamine/0.9% NaCl (pH 8.0) for 10 min at room temperature. Sections were transferred through 70 (1 min), 80 (1 min), 95 (2 min), and 100% ethanol (1 min); 100% chloroform (5 min); and 100 (1 min) and 95% ethanol (1 min); and dried. All control and experimental sections were hybridized in the same hybridization reaction.

The AVP intronic probe, a synthetic 36-base oligonucleotide corresponding to the first 36 bases of rat AVP intron I (AVPin) (39), was made, as described (20). The AVP exonic probe (AVPex) was a 48-base oligonucleotide complementary to part of the exonic mRNA sequence coding for AVP. The specificity of AVPin (36, 40) and AVPex (40) probes has previously been determined. The probes were labeled with 35S-deoxyATP, as previously described (20). The hybridization procedures were carried out, as previously described (13, 40). In brief, sections were hybridized overnight at 37 C with 5 x 105 cpm labeled AVPin or 3 x 105 cpm AVPex probe per 2 sections, then washed in four 15-min rinses of 1 x SSC (1 x SSC = 0.15 M NaCl and 0.015 M sodium citrate, pH 7.0) on shaking waterbath (55 C), followed by two 30-min rinses in 1 x SSC at room temperature.

The rat CRH intron (CRHin) probe was generated from a 530-bp pvuII fragment of the CRH gene subcloned into PGem 3 and linearized by XbaI (which was kindly supplied by Dr. Bob Thompson). The rat CRH (CRHex 2) complementary DNA (41) used same source with CRHin) was a 770-bp BamH1 fragment subcloned in PGem3Z, linearized by HindIII. The 35S-labeled cRNA probes for CRHin and CRHex were produced as previously described (20). The specificity of CRHin and CRHex probes was confirmed by sense-strand cRNA probes, respectively (42). Sections were hybridized at 55 C with 1 x 106 cpm-labeled CRHin or CRHex probe per slide containing 2 sections; and then nonspecifically hybridized probe was removed by washing 2 times with 2 x SSC containing 50% formamide at 50 C, incubated with ribonuclease A for 30 min at 37 C, followed by 2 washings 3 times with 2 x SSC containing 50% formamide at 50 C, and 2 times with 2 x SSC at room temperature for 10 min. Finally, slides were dipped in water and air dried.

Plasma corticosterone assays
Total plasma corticosterone was determined in plasma (5 µl diluted in 500 µl buffer) by RIA as described previously (16). 125I-corticosterone was used as the tracer with a specific activity of 2–3 mCi/mg. Corticosterone antibody was a kind gift of Dr. Gabor Makara, Budapest. The sensitivity of the assay was 25 ng/ml.

Analysis and quantification
For quantification of CRH hnRNA and CRH mRNA in the PVN, the sections and 14C-labeled standards of known radioactivity (American Radiochemical, St. Louis, MO) were placed in x-ray cassettes, then exposed to Hyperfilm MP autoradiography film (Amersham International Plc, Amersham, UK) for 3 days (CRHex) and 15 days (CRHin). For cellular localization of AVP and CRH hybrids, the slides were subsequently dipped in nuclear emulsion (Ilford Scientific Product K-5, Ilford, Essex, UK) and exposed for appropriate times (AVPin, 50 days; AVPex, 9 days; CRHin, 35 days; CRHex, 12 days). The slides were counterstained with cresyl violet acetate (Sigma, Dorset, UK). The optical density of autoradiographic images was measured by using a computerized image analysis system, as described (16). In brief, the autoradiographic image of probe bound to parvocellular CRH mRNA and CRH hnRNA, together with 14C-labeled standards, were measured using a computerized image analysis system (Image 1.22, developed by W. Rasband, NIH) on an Apple Mac IICi computer. The optical densities were obtained in two consecutive sections per rat, the average value for each rat was used to calculate group means, and the results are presented as means percentage change from control with SEM. Analysis of changes in the prevalence of AVP transcripts in the medial parvocellular and posterior magnocellular subdivisions of the PVN was carried out in the cresyl violet counterstained sections using a x40 objective for AVP mRNA and a x100 oil immersion objective for AVP hnRNA, with brightfield condenser, as described (20, 23). Briefly, the medial parvocellular AVP neurons in the PVN were differentiated histologically from magnocellular neurons on the basis of their overall size, their relatively low level of AVP expression, and their small, dense-staining nuclei. Magnocellular cells in the medial parvocellular subdivision were characterized by large numbers of superimposed silver grains, relatively faint nuclear and Nissl cytoplasmic staining, and their large size. The neurons in the medial parvocellular subdivision of the PVN were considered to be positive for AVP hnRNA if overlying grain densities were at least three times that of background, measured in the vicinity of the labeled cells. The relative levels of AVP hnRNA and mRNA were quantified in the medial parvocellular and posterior magnocellular subdivisions of PVN using computerized densitometry, as described above on coronal sections, subtracting background from the proximity of the measured cells. Scattered magnocellular cells in the medial parvocellular subdivision of the PVN were excluded from the analysis on the basis of their histological appearance. For each animal, at least 4 PVNs on two sections were assessed; the average value of each section for each rat was used to calculate group means. The results are presented as means percentage change from control with SEM.

Statistical analysis was performed by one-way ANOVA, followed by the Fisher least significant difference procedure (PLSD) test, to assess statistical significance between the control and experimental groups at each time point. P < 0.05 was considered to be statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Plasma corticosterone
There was no significant difference between basal corticosterone level, after 13 days repeated stress, and the level found in the control group of rats. After immobilization, the repeatedly immobilized animals still showed a prompt release of corticosterone, which peaked at 15 min and remained raised at 90 min before returning to basal levels (Fig. 1Go), although the levels themselves were less than those seen in the control animals (control animals: time 0 min, 62.6 ± 12.3; 30 min, 569.62 ± 41.9; 60 min, 522.9 ± 48.9; 120 min, 41.9 ± 5.03 ng/ml) (repeatedly immobilized animals: time 0 min, 73.7 ± 11.0; 30 min, 273.5 ± 51.03; 60 min, 162.42 ± 19.68; 120 min, 47.43 ± 11.47 ng/ml).



View larger version (38K):
[in this window]
[in a new window]
 
Figure 1. The time course of plasma corticosterone response to acute restraint in repeatedly restrained rats. C-rats were handled daily. The time point on the x-axis represents the time after the onset of the 90-min period of restraint on day 14. Values are presented as means ± SEM. #, P < 0.05, compared with 0 min; *, P < 0.01, compared with control (one-way ANOVA followed by Fisher PLSD test).

 
Levels of CRH RNAs
Under basal conditions, CRH hnRNA expression was very low, although CRH hnRNA transcripts can clearly be seen in the parvocellular neurons of the hypothalamic PVN (Fig. 2aGo). No silver grains were observed in the parvocellular neurons hybridized with CRH sense riboprobe (Fig. 2bGo). There was no significant difference between basal CRH hnRNA or mRNA levels, after 13 days of repeated stress, and the levels found in the control animals. After restraint, there was no significant increase in either CRH hnRNA or mRNA levels in these repeatedly stressed animals (Fig. 2Go, C and D; Fig. 4Go; also see Fig. 5Go).



View larger version (119K):
[in this window]
[in a new window]
 
Figure 2. Effect of acute restraint on CRH hnRNA in the hypothalamic PVN in daily handled control (A) and stressed rats (C, D). Under unstressed conditions, CRH hnRNA expression is very low, but the signal could be clearly seen in the medial parvocellular neurons of the PVN (A). No labeled neurons were observed in the parvocellular PVN hybridized with sense riboprobe, and the arrow points to an example of an unlabeled nucleus (B). The level of CRH hnRNA in the parvocellular neurons did not increase at 30 min (C) and 90 min (D) after the onset of the last period of stress. Magnification, x400.

 


View larger version (152K):
[in this window]
[in a new window]
 
Figure 4. Effect of acute restraint on CRH mRNA and AVP mRNA in the parvocellular subdivision of the PVN in daily handled control and stressed rats. The level of CRH mRNA in the parvocellular neurons of the PVN did not significantly increase at 4 h after the onset of the last period of restraint (B), compared with daily handed control (A). However, the level of AVP mRNA in the medial parvocellular (MP) neurons of the PVN significantly increased and peaked at 3 h after the onset of the last period of restraint (D), compared with daily handed control (C). PM, Posterior magnocellular subdivision of the PVN. 3V, Third ventricle. Magnification: A–B, x63; C–D, x100.

 


View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. The time course of CRH hnRNA and mRNA in the PVN response to acute restraint in repeatedly restrained rats. C-rats were handled daily. The time point on the x-axis represents the time after the onset of the 90-min period of restraint on day 14. Changes of CRH hnRNA or mRNA levels were not detected at any time point before or after the onset of the last period of restraint. Values are presented as means ± SEM (one-way ANOVA followed by Fisher PLSD test).

 
Levels of AVP RNAs
AVP hnRNA expression in the parvocellular neurons of the hypothalamic PVN were extremely low under normal unstressed conditions (Fig. 3Go, A and B). There was no significant difference between basal AVP hnRNA or mRNA levels in the parvocellular subdivision of the PVN, after 13 days of repeated stress, and the levels found in control animals. After restraint of these repeatedly stressed animals, there was a very prompt increase in AVP hnRNA levels in the parvocellular PVN, which was significant at 15 min, peaked at 60 and 90 min, and rapidly returned to basal levels at 2 h (within 30 min of return to their home cage from the restrainer) (Fig. 3Go, C and D; also see Fig. 6Go). AVP mRNA responded more slowly, reaching a significant increase at 90 min and remaining raised at 4 h (Figs. 4Go and 6Go).



View larger version (128K):
[in this window]
[in a new window]
 
Figure 3. Effect of acute restraint on AVP hnRNA in the parvocellular subdivision of the PVN in daily handled control (A, B) and stressed rats (C, D). Under unstressed conditions, AVP hnRNA expression is extremely low in medial parvocellular neurons (MP) of the PVN (A, B). The level of AVP hnRNA in the parvocellular neurons (small arrows) significantly increased and peaked at 60 min (C, D) after the onset of the last period of stress. PM, Posterior magnocellular neurons (big arrows) of the PVN. Magnification: A and C, x200; B and D, x400.

 


View larger version (26K):
[in this window]
[in a new window]
 
Figure 6. The time course of AVP hnRNA and mRNA in the medial parvocellular subdivision of the PVN (parvoAVP hnRNA and parvoAVP mRNA) response to acute restraint in repeatedly restrained rats. C-rats were handled daily. The time point on the x-axis represents the time after the onset of the 90-min period of restraint on day 14. Values are presented as means ± SEM. *, P < 0.05, compared with control; **, P < 0.01, compared with control; #, P < 0.05, compared with 0 min; ##, P < 0.01, compared with 0 min (one-way ANOVA followed by Fisher PLSD test).

 
Magnocellular PVN AVP hnRNA and mRNA were also measured throughout the study. No changes in either RNA were found at any time point (Fig. 7Go).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 7. The time course of AVP hnRNA and mRNA in the posterior magnocellular subdivision of the PVN (pmAVP hnRNA and pmAVP mRNA) response to acute restraint in repeatedly restrained rats. C-rats were handled daily. The time point on the x-axis represents time after the onset of the 90-min period of restraint on day 14. The changes of pmAVP hnRNA or mRNA contents were not detected at any time point before or after the onset of the last period of restraint. Values are presented as means ± SEM (one-way ANOVA followed by Fisher PLSD test).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study was designed to investigate the changes in hypothalamic response that occur during the process of adaptation to repeated stress. The response of the HPA to chronic or repeated stress varies according to the type of stress (43). We have previously shown that the response of parvocellular PVN CRH mRNA to daily restraint rapidly desensitizes, with a complete loss of response occurring after 12 days (14). Other stress paradigms provide different results, some resulting in increased CRH mRNA levels in the PVN (19, 24, 26, 27, 28, 29, 44), whereas chronic stress can decrease the level of CRH mRNA in the PVN (30). These data suggest that the responses of CRH transcripts, in the PVN, to repeated stress are stressor specific, and we therefore decided to carry out a detailed investigation of a paradigm in which a degree of adaptation was known to occur.

We chose the simple stimulus of daily restraint and carried out these studies in the Wistar strain of rat, which has been extensively studied in stress research and which has very similar CRH mRNA, AVP mRNA, proenkephalin A mRNA, and corticosterone responses to the other frequently studied strain (the Sprague-Dawley) (16). We have previously shown that in naive Wistar rats, acute restraint stress results in a very rapid increase of CRH hnRNA level, to more than 1,000% (as reflected by probe binding) of control values, with CRH mRNA only increasing significantly at 4 h. AVP hnRNA approximately doubled at 60 min, and AVP mRNA showed a significant increase at 4 h (20). After 13 days of restraint, we found a very marked change in the pattern of the hypothalamic response to stress. The CRH hnRNA and mRNA responses were completely abolished, whereas the response of AVP gene transcription showed no diminution and, if anything, increased. AVP hnRNA was significantly elevated within 15 min and was increased about 3-fold at 60 and 90 min, before falling to baseline values at 2 h (just 30 min after the animal returned to its home cage). AVP mRNA was significantly increased by 90 min and remained raised up to 4 h, reaching peak levels of approximately 3 times basal value. The up-regulation of parvocellular AVP gene transcription in this experimental model is consistent with previous studies showing that parvocellular AVP mRNA levels rise significantly after repeated immobilization (19, 27) or repeated foot shock (44). The response does, however, differ from that seen after multiple varied stressors, which would not be expected to result in the same degree of adaptation (26). These data suggest that AVP synthesized in the parvocellular PVN plays an important role in activating the HPA axis under conditions of chronic stress and may be necessary for the resistance of the HPA axis to adaptation in response to such repeated stress (9).

The significant increase of AVP transcription, but not CRH transcription, in the parvocellular PVN represents a remarkable transcript-specific alteration in gene regulation and supports the hypothesis that parvocellular AVP and CRH gene expression in the PVN may have quite different transcriptional control mechanisms (26). It is interesting that vasopressin-immunoreactive parvocellular neurons in the PVN are identical to CRH neurons, and vasopressin-positive parvocellular neurons are always stained for CRH (45, 46). Under normal resting conditions, AVP is expressed in a subpopulation of CRH-positive neurons in the PVN and colocalizes with approximately 50% of CRH-positive terminals in the median eminence (6, 7). Repeated immobilization increases the proportion of CRH parvocellular neurons containing AVP to 90% and results in a 2-fold increase in the number of AVP positive parvocellular neurons, whereas the number of CRH parvocellular neurons remains at a normal level (27). In addition, repeated immobilization does not affect CRH stores but significantly increases the AVP stores and colocalization of AVP with CRH in the median eminence (34). The proportion of CRH-expressing cells in the parvocellular PVN that also express AVP increases substantially in response to repeated stress (35). Furthermore, repeated immobilization induces an increase in AVP-binding affinity and AVP V1b receptor mRNA in the pituitary (47). Our results, taken together with these published data, suggest that repeated restraint does activate CRH parvocellular neurons to express AVP but not CRH (an adaptive change whose mechanism is not understood).

Another interesting result is the fact that after repeated restraint, there is still a marked corticosterone response to stress, in the absence of any change in hypothalamic CRH gene transcription. Although we cannot be sure that the lack of change in CRH RNA reflects lack of peptide release from the median eminence, we have shown previously that the reduction of CRH mRNA in chronic arthritis does correlate with reduced levels of hypothalamic pituitary portal CRH-41 (30). It certainly seems likely that the HPA response seen in our repeated restraint paradigm results predominantly from the hypothalamic release of AVP rather than CRH.

In conclusion, after a repeated restraint, there is a transcript-specific alteration in gene regulation within the parvocellular cells of the PVN, in which CRH gene transcription is desensitized, but AVP gene transcription is maintained. These data provide further evidence of the importance of AVP in the activation of the HPA axis during chronic or repeated stress.


    Acknowledgments
 
The authors would like to thank Dr. Greti Aguilera for her support and suggestions in the preparation of this manuscript, and Susan Wood for her help in measuring plasma corticosterone concentration.


    Footnotes
 
1 This work was supported by a grant from the Neuroendocrinology Charitable Trust (to X.-M.M.). Back

2 Present address: Xin-Ming Ma, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institute of Health, Building 10, Room 10N262, Bethesda, Maryland 20892. Back

Received April 24, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7:351–378[Abstract/Free Full Text]
  2. Antoni FA 1993 Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14:76–122[CrossRef][Medline]
  3. Lightman SL, Harbuz MS, Knight RA, Chowdrey HS 1993 CRH mRNA in normal and stress conditions. Ann NY Acad Sci 698:28–38
  4. Rivier CL, Plotsky PM 1986 Mediation by corticotrophin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 48:475–494[CrossRef][Medline]
  5. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J 1983 Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 39:245–270
  6. Whitnall MH, Smith D, Gainer H 1987 Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats. Neuroendocrinology 45:420–424[Medline]
  7. Wolfson B, Manning RW, Davis LG, Arentzen R, Baldino Jr F 1985 Colocalization of corticotropin-releasing factor (CRF), and vasopressin mRNA in neurons after adrenalectomy. Nature 315:59–61[CrossRef][Medline]
  8. Whitnall MH 1993 Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40:573–629[Medline]
  9. Scaccianoce S, Muscolo LAA, Cigliana G, Navarra D, Nicolai R, Angelucci L 1991 Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 128:3138–3143[Abstract/Free Full Text]
  10. Liu J-P, Clarke IJ, Funder JW, Engler D 1990 The biosynthesis and secretion of adrenocorticotropin by the ovine anterior pituitary is predominantly regulated by arginine vasopressin (AVP). J Biol Chem 2651:14136–14142
  11. Rivier C, Rivier J, Mormede P, Vale W 1984 Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor in adrenocorticotropin release in rat. Endocrinology 115:882–886[Abstract/Free Full Text]
  12. Gillies GE, Linton EA, Lowry PJ 1982 Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355–357[CrossRef][Medline]
  13. Lightman SL, Young III WS 1988 Corticotropin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rats. J Physiol (Lond) 403:511–523[Abstract/Free Full Text]
  14. Lightman SL, Harbuz MS 1993 Expression of corticotropin releasing factor mRNA in response to stress. In: Chadwick DJ, Marsh J, Ackill K (eds) Corticotropin-Releasing Factor. Wiley, Chichester, UK, pp 173–188
  15. Harbuz MS, Lightman SL 1988 Response of hypothalamus and pituitary mRNA to physiological stress in the rat. J Endocrinol 122:705–711[CrossRef]
  16. Harbuz MS, Jessop DS, Lightman SL, Chowdrey HS 1994 The effect of restraint or hypertonic saline stress on corticotropin-releasing factor, arginine vasopressin, and proenkephalin A mRNAs in the CFY, Sprague and Wistar strains of rat. Brain Res 667:6–12[CrossRef][Medline]
  17. Imaki T, Shibasaki T, Hotta M, Demura H 1992 Early induction of c-fos precedes increased expression of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus after immobilization stress. Endocrinology 132:240–246
  18. Kalin NH, Takahashi LK, Chen F-L 1994 Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res 656:182–186[CrossRef][Medline]
  19. Makino S, Smith MA, Gold PW 1995 Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 136:3299–3309[Abstract]
  20. Ma X-M, Levy A, Lightman SL 1997 Rapid changes in heteronuclear RNA for corticotropin-releasing hormone and arginine vasopressin in response to acute stress. J Endocrinol 152:81–89[Abstract/Free Full Text]
  21. Darlington DN, Barraclough CA, Gann DS 1992 Hypotensive hemorrhage elevates corticotropin-releasing hormone messenger ribonucleic acid (mRNA) but not vasopressin mRNA in the rat hypothalamus. Endocrinology 130:1281–1288[Abstract/Free Full Text]
  22. Bartanusz V, Aubry J-M, Steimer T, Baffi J, Kiss JZ 1994 Stressor-specific increase of vasopressin mRNA in paraventricular hypophysiotrophic neurons. Neurosci Lett 170:35–38[CrossRef][Medline]
  23. Herman JP 1995 In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. J Comp Neurol 363:15–27[CrossRef][Medline]
  24. Lightman SL, Young III WS 1989 Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress. Proc Natl Acad Sci USA 86:4306–4130[Abstract/Free Full Text]
  25. Herman JP, Schafer MK-H, Sladek CD, Day R, Young EA, Akil H, Watson SJ 1989 Chronic electroconvulsive shock treatment elicits up regulation of CRH and AVP in select populations of neuroendocrine neurons. Brain Res 501:235–246[CrossRef][Medline]
  26. Herman JP, Adams D, Prewitt C 1995 Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 61:180–190[CrossRef][Medline]
  27. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ 1993 Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132:895–902[Abstract/Free Full Text]
  28. Mamalaki E, Kvetnansky R, Brady LS, Gold PV, Herkenham M 1992 Repeated immobilization stress alters tyrosine hydroxylase, corticotropin-releasing hormone and corticosteroid receptor messenger ribonucleic acid levels in rat brain. J Neuroendocrinol 4/5:689–699
  29. Gomez F, Lahmame A, de Kloet ER, Armario A 1996 Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential response are mainly located at the adrenocortical level. Neuroendocrinology 63:327–337[Medline]
  30. Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL 1992 Paradoxical response of Hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology 130:1394–1400[Abstract/Free Full Text]
  31. Hauger RL, Millan MA, Lorang M, Harwood JP, Aguilera G 1988 Corticotropin-releasing factor receptor and pituitary adrenal responses during immobilization stress. Endocrinology 123:396–405[Abstract/Free Full Text]
  32. Hauger RL, Millan MA, Lorang M, Irwin M, Aguilera G 1990 CRF receptor regulation and sensitization of ACTH responses to acute stress during chronic stress intermitted immobilization stress. Brain Res 532:34–40[CrossRef][Medline]
  33. Hashimoto K, Suemaru S, Takao T, Sugawara M, Makino S, Ota Z 1988 Corticotropin-releasing hormone and pituitary adrenocortical responses in chronically stressed rat. Regul Pept 23:117–126[CrossRef][Medline]
  34. deGoeij DEC, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJH 1991 Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin releasing factor neurons in the median eminence of rats. Neuroendocrinology 53:150–159[Medline]
  35. deGoeij DEC, Jezova D, Tilders FJH 1992 Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 577:165–168[CrossRef][Medline]
  36. Priou A, Oliver C, Grino M 1993 In situ hybridization of arginine vasopressin (AVP) heteronuclear ribonucleic acid reveals increased AVP gene transcription in the rat hypothalamic paraventricular nucleus in response to emotional stress. Acta Endocrinol (Copenh) 128:466–472[Abstract/Free Full Text]
  37. Imaki T, Wang X-Q, Shibasaki T, Yamada K, Harada S, Chikada N, Naruse M, Demura H 1995 Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoid in rats. J Clin Invest 96:231–238
  38. Kovcs KJ, Sawchenko PE 1996 Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 16:262–273[Abstract/Free Full Text]
  39. Schmale H, Heisohn S, Richter D 1983 Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor. EMBO J 2:763–767[Medline]
  40. Young III WS, Mezey E, Siegel RE 1986 Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett 70:231–241
  41. Thompson RC, Seasholtz AF, Herbert E 1987 Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. Mol Endocrinol 1:363–370[Abstract/Free Full Text]
  42. Herman JP, Schafer MKH, Thompson RC, Watson SL 1992 Rapid regulation of corticotropin-releasing hormones gene transcription in vivo. Mol Endocrinol 6:1061–1069[Abstract/Free Full Text]
  43. Aguilera G 1994 Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15:321–350[CrossRef][Medline]
  44. Sawchenko PE, Arias CA, Mortrud MT 1993 Local tetrodoxin blocks chronic stress effects on corticotropin-releasing factor and vasopressin messenger ribonucleic acid in hypophysiotropic neurons. J Neuroendocrinol 5:341–348[CrossRef][Medline]
  45. Kiss JZ, Mezey E, Skirboll L 1984 Corticotropin-releasing factor immuno-reactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Prol Natl Acad Sci USA 84:1854–1858
  46. Sawchenko PE, Swanson LW, Vale W 1987 Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA 81:1883–1887
  47. Rabadan-Diehl C, Lolait SJ, Aguilera G 1995 Regulation of pituitary vasopressin V1b receptor mRNA during stress in rat. J Neuroendocrinol 7:903- 910[CrossRef][Medline]



This article has been cited by other articles:


Home page
J EndocrinolHome page
F. Spiga, L. R Harrison, S. Wood, D. M Knight, C. P MacSweeney, F. Thomson, M. Craighead, and S. L Lightman
Blockade of the V1b receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity
J. Endocrinol., March 1, 2009; 200(3): 273 - 283.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
F. Spiga, L. R Harrison, C. P MacSweeney, F. J Thomson, M. Craighead, and S. L Lightman
Effect of vasopressin 1b receptor blockade on the hypothalamic-pituitary-adrenal response of chronically stressed rats to a heterotypic stressor
J. Endocrinol., March 1, 2009; 200(3): 285 - 291.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Al-Noori, N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, A. Zavosh, C. West, C. M. Sanders, and D. P. Figlewicz
Recurrent hypoglycemia alters hypothalamic expression of the regulatory proteins FosB and synaptophysin
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1446 - R1454.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Rice, C. A. Sandman, M. R. Lenjavi, and T. Z. Baram
A Novel Mouse Model for Acute and Long-Lasting Consequences of Early Life Stress
Endocrinology, October 1, 2008; 149(10): 4892 - 4900.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. E. Bates, A. S. Sirek, M. A. Kiraly, J. T. Y. Yue, D. Goche Montes, S. G. Matthews, and M. Vranic
Adaptation to Mild, Intermittent Stress Delays Development of Hyperglycemia in the Zucker Diabetic Fatty Rat Independent of Food Intake: Role of Habituation of the Hypothalamic-Pituitary-Adrenal Axis
Endocrinology, June 1, 2008; 149(6): 2990 - 3001.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Subburaju and G. Aguilera
Vasopressin Mediates Mitogenic Responses to Adrenalectomy in the Rat Anterior Pituitary
Endocrinology, July 1, 2007; 148(7): 3102 - 3110.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Yao, M. Stenzel-Poore, and R. J. Denver
Structural and Functional Conservation of Vertebrate Corticotropin-Releasing Factor Genes: Evidence for a Critical Role for a Conserved Cyclic AMP Response Element
Endocrinology, May 1, 2007; 148(5): 2518 - 2531.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. J. Lolait, L. Q. Stewart, D. S. Jessop, W. S. Young 3rd, and A.-M. O'Carroll
The Hypothalamic-Pituitary-Adrenal Axis Response to Stress in Mice Lacking Functional Vasopressin V1b Receptors
Endocrinology, February 1, 2007; 148(2): 849 - 856.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Kawasaki, T. Onaka, M. Nakazato, J. Saito, T. Mera, H. Hashimoto, H. Fujihara, N. Okimoto, H. Ohnishi, T. Nakamura, et al.
Centrally administered neuropeptide W-30 activates magnocellular neurosecretory cells in the supraoptic and paraventricular nuclei with neurosecretion in rats.
J. Endocrinol., August 1, 2006; 190(2): 213 - 223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Park, O. Chan, Q. Li, M. Kiraly, S. G. Matthews, M. Vranic, and M. C. Riddell
Changes in basal hypothalamo-pituitary-adrenal activity during exercise training are centrally mediated
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1360 - R1371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Chan, K. Inouye, E. M. Akirav, E. Park, M. C. Riddell, S. G. Matthews, and M. Vranic
Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R235 - R246.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Vandenborne, B. De Groef, S. M. E. Geelissen, G. C. Boorse, R. J. Denver, E. R. Kuhn, V. M. Darras, and S. Van der Geyten
Molecular Cloning and Developmental Expression of Corticotropin-Releasing Factor in the Chicken
Endocrinology, January 1, 2005; 146(1): 301 - 308.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Zelena, Z. Mergl, A. Foldes, K. J. Kovacs, Z. Toth, and G. B. Makara
Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1110 - E1117.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. P. H. Burbach, S. M. Luckman, D. Murphy, and H. Gainer
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Physiol Rev, July 1, 2001; 81(3): 1197 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. J. Kovacs, A. Foldes, and P. E. Sawchenko
Glucocorticoid Negative Feedback Selectively Targets Vasopressin Transcription in Parvocellular Neurosecretory Neurons
J. Neurosci., May 15, 2000; 20(10): 3843 - 3852.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X.-M. Ma, S. L. Lightman, and G. Aguilera
Vasopressin and Corticotropin-Releasing Hormone Gene Responses to Novel Stress in Rats Adapted to Repeated Restraint
Endocrinology, August 1, 1999; 140(8): 3623 - 3632.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ferin
Stress and the Reproductive Cycle
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1768 - 1774.
[Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Bonaz and S. Rivest
Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1438 - R1449.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
X.-M. Ma and S. L Lightman
The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats
J. Physiol., July 15, 1998; 510(2): 605 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Xiao, L. Xia-Zhang, A. Barth, J. Zhu, and M. Ferin
Stress and the Menstrual Cycle: Relevance of Cycle Quality in the Short- and Long-Term Response to a 5-Day Endotoxin Challenge during the Follicular Phase in the Rhesus Monkey
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2454 - 2460.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, X.-M.
Right arrow Articles by Lightman, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X.-M.
Right arrow Articles by Lightman, S. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals